Table 2.
The correlation between LINC00346 expression and clinical features in 229 patients with PCa
| All cases | LINC00346 | |||
|---|---|---|---|---|
|
| ||||
| High expression | Low expression | P value | ||
| Age (year) | ||||
| > 60 | 108 | 52 (48.1%) | 56 (51.9%) | 0.516 |
| ≤ 60 | 121 | 59 (48.8%) | 62 (51.2%) | |
| Differentiation | ||||
| Well | 69 | 31 (44.9%) | 38 (55.1%) | 0.520 |
| Moderate | 87 | 41 (47.1%) | 46 (52.9%) | |
| Poor | 73 | 32 (43.8%) | 41 (56.2%) | |
| pN status | 0.001 | |||
| N0 | 123 | 47 (38.2%) | 76 (61.8%) | |
| N1-N2 | 106 | 64 (60.4%) | 42 (39.6%) | |
| pM status | 0.100 | |||
| M0 | 156 | 75 (47.5%) | 83 (52.5%) | |
| M1 | 73 | 42 (57.5%) | 31 (42.5%) | |
| Clinical stage | 0.391 | |||
| I | 79 | 46 (58.2%) | 33 (41.8%) | |
| II | 58 | 27 (46.6%) | 31 (53.4%) | |
| III | 53 | 34 (64.2%) | 19 (35.8%) | |
| IV | 39 | 22 (56.4%) | 17 (43.6%) | |
pN: pathological node; pM: pathological metastasis.